BiotechTubeBiotechTube
Home/ClearNote Health/Samuel Levy, PhD
SL

Samuel Levy, PhD

Chief Scientific Officer

ClearNote Health

Therapeutic Areas

Oncology

ClearNote Health Pipeline

DrugIndicationPhase
Avantect® Pancreatic Cancer TestEarly detection of pancreatic cancerApproved/Commercial
Avantect® Ovarian Cancer TestEarly detection of ovarian cancerApproved/Commercial
Avantect (Pipeline)Lung Cancer Detection (Non-Small Cell Lung Cancer)R&D
Virtuoso PlatformPredictive biomarkers for radioligand therapy (Pancreatic NET)R&D/Collaboration

Leadership Team at ClearNote Health

DM
Dave Mullarkey
Chief Executive Officer
JM
Jeffrey M. Venstrom, MD
Chief Medical Officer
WV
Wayne Volkmuth, PhD
Senior Vice President, Informatics & Data Discovery
SQ
Steve Quake, D.Phil.
Founder (Inspired company from Stanford laboratory)
View full ClearNote Health profile